Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1998, p. 3505-3508, Vol. 36, No. 12
B.C. Centre for Disease Control Society,
Vector-Borne Diseases Laboratory, Vancouver, British Columbia V5Z 4R4,
Canada,1 and
Rocky Mountain
Laboratories, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Hamilton, Montana
598402
Received 8 July 1998/Returned for modification 18 August
1998/Accepted 3 September 1998
The spirochete that causes tick-borne relapsing fever,
Borrelia hermsii, was isolated in pure culture during 1995 and 1996 from three acutely ill human patients infected in southern
British Columbia, Canada. The geographic area of exposure is a known
focus of this disease dating back to 1930 when the first case was
recognized in a human. Analyses of plasmid DNA, protein profiles, and
reactivity with a species-specific monoclonal antibody identified the
new isolates of spirochetes as B. hermsii, all of which
were most similar to an isolate of this spirochete from northern
California described previously. These are the first reported isolates
of B. hermsii from Canada.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Tick-Borne Relapsing Fever in British Columbia,
Canada: First Isolation of Borrelia hermsii
*
Corresponding author. Mailing address: Rocky Mountain
Laboratories, 903 South 4th St., Hamilton, MT 59840. Phone: (406)
363-9250. Fax: 406 363-9371. E-mail: tom_schwan{at}nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»